Back to calendar
Aligos Therapeutics, Inc. (ALGS) Earnings
ALGS reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026
Q2 2026
Est. EPS: $-2.46
Actual EPS: $-0.14
EPS surprise: 87.20%
Company overview
Market Cap$35.1M
PriceUSD 5.67
EPS (TTM)-8.70
52-week high13.69
52-week low3.98
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees82